Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement
Clinical trial NCT03724084 · TERMINATED
Trial details
- NCT number
- NCT03724084
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-10
- Primary completion
- 2022-11-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.